Atlas Trials

Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy Subjects

Clinical trial NCT04367441 · UNKNOWN

Trial details

NCT number
NCT04367441
Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Moderate to Severe Plaque Psoriasis
Start date
2019-11-25
Primary completion
2020-10-31
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.